The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort

dc.contributor.authorUslu, Sadettin
dc.contributor.authorGulle, Semih
dc.contributor.authorCan, Gercek
dc.contributor.authorSenel, Soner
dc.contributor.authorCapar, Sedat
dc.contributor.authorDalkilic, Huseyin Ediz
dc.contributor.authorSari, Ismail
dc.date.accessioned2026-08-12T18:12:56Z
dc.date.issued2022
dc.departmentFırat Üniversitesi
dc.descriptionAnnual Meeting of the American-College-of-Rheumatology (ACR) -- NOV 10-14, 2022 -- Philadelphia, PA
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipAmer Coll Rheumatol
dc.identifier.endpage849
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.startpage847
dc.identifier.urihttps://hdl.handle.net/11508/64129
dc.identifier.volume74
dc.identifier.wosWOS:000877386500424
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofArthritis & Rheumatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleThe Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort
dc.typeConference Object

Dosyalar